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ORIGINAL RESEARCH
INTERVENTIONAL
Modifying Flow in the ICA Bifurcation: Pipeline Deployment
from the Supraclinoid ICA Extending into theM1 Segment—
Clinical and Anatomic Results
E. Nossek, D.J. Chalif, S. Chakraborty, and A. Setton
ABSTRACT
BACKGROUNDAND PURPOSE: Utility of the Pipeline Embolization Device extending to theM1 and its clinical and ﬂow consequences at
the ICA bifurcation have not been characterized. We analyzed ﬂowmodiﬁcation in cases where a single Pipeline Embolization Device was
deployed from the M1 to the distal supraclinoid ICA, covering the A1, for aneurysm treatment.
MATERIALS AND METHODS: A1 ﬂow modiﬁcations and size regression in postprocedure and follow-up angiography were analyzed.
Vessel diameters and ratios of the proximal A1 and M1 segments and the distal ICA were assessed. Relationships between Pipeline
Embolization Device nominal diameter and the vessel diameters at landing zones were obtained. Clinical assessments after ﬂow modiﬁ-
cation were documented.
RESULTS: Six of 7 patients demonstrated no change of ﬂow in the anterior cerebral artery/anterior communicating artery complex at
immediate postembolization angiography. All patients who underwent follow-up angiography demonstrated size regression of the
ipsilateral A1. Midterm follow-up angiography revealed complete reversal of ﬂow in the ipsilateral A1 in 4 of 5 patients. One patient did not
demonstrate ﬂow modiﬁcation. This patient had a dominant ipsilateral A1. Vessel ratios in this case demonstrated a unique conﬁguration
in favor of maintaining patency of the ipsilateral A1. There were no clinical or radiographic signs of ischemia. One patient experienced
asymptomatic angiographic in-stent stenosis at the M1.
CONCLUSIONS: We found that deployment of a Pipeline Embolization Device from the distal supraclinoid ICA to the M1 may result in
reversal of ﬂow in the anterior cerebral artery/anterior communicating artery complex and regression of the ipsilateral A1. Preoperative
anatomic quantitation and sizing of the Pipeline Embolization Device may predict ﬂow modiﬁcation results.
ABBREVIATIONS: ACA  anterior cerebral artery; AchoA  anterior choroidal artery; AcomA  anterior communicating artery; FD  ﬂow diverter; ICAb 
internal carotid artery bifurcation; OphA ophthalmic artery; PED Pipeline Embolization Device
Flow-diverter (FD) devices were originally reported to modifyand redirect flow as a treatment option for wide-neck aneu-
rysms.1,2 Recently, extended use for FDs formore distal and small
aneurysms has also been described.3-6 The Pipeline Embolization
Device (PED; Covidien, Irvine, California) has been approved
specifically to treat wide-neck proximal ICA aneurysms at the
cavernous and ophthalmic segments.2 There are cases, however,
where the PEDmay be used to treat wide-neck aneurysms that are
located distal to the ophthalmic segment, at the level of the pos-
terior communicating artery or the anterior choroidal artery
(AchoA) segments, as well as those located at the ICA bifurcation
(ICAb).
The minimal PED landing length that is recommended to
achieve both good anchoring of the stent and efficient flow diver-
sion is approximately 5 mm proximal and 5 mm distal to the
aneurysmal neck. In cases where the length of the ICA from the
distal neck of the aneurysm to the ICA bifurcation is shorter than
5 mm, or alternately, if the treated aneurysm is an ICAb aneu-
rysm, the distal PED should land and be anchored in the proximal
M1 segment. Descriptions of PED deployment that cover the A1
segment origin are rare6; in addition, flow modification at the
level of the ICAb is challenging to predict. In our review of the
current literature, we did not find any descriptions of the hemo-
dynamic effects or clinical efficacy of PED deployment in the
ICAb extending to the M1 segment.
We described our experience with cases of PED deployment
extending into theM1 segment and focused on the anatomic flow
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modifications achieved at the ICAb. We have analyzed this tech-
nique quantitatively in respect to comparative preoperative ante-
rior circle ofWillis angioarchitecture and vessel diameters, and in
respect to the specific PED dimensions used.
MATERIALS AND METHODS
This is a retrospective review of patients whowere treated for supra-
clinoid ICA aneurysms between 2012 and 2013 at our institution
(Institutional Review Board approval number 13-303). In this co-
hort, PEDs were deployed from the proximal M1 segment to the
distal supraclinoid ICA.Flowassessmentswereperformedbefore the
procedure to predict the competence of the
collateral circulation (contralateral ICA, bi-
lateral A1 segments, and the anterior com-
municating artery [AcomA]) to supply
bothanterior cerebral arteries (ACAs). Inall
cases, a single PED was deployed, covering
the ipsilateral A1 segment (Fig 1). In cases
where a second PED was used (either for
additional aneurysmal neck coverage or for
proximal anchoring of the first PED due to
lack of proper wall apposition), there was
specifically no additional duplicated PED
coverage over the origin of the ipsilateral A1
segment or over the AchoA.
Absolute anatomic vessel diameters
and ratios between the sizes of the proxi-
mal aspects of the A1 segments, M1 seg-
ments, and the distal supraclinoid ICA
were assessed in calibrated DSA images.
Ratios between the PED nominal diame-
ter and the diameters of the proximal M1
segment and ICA at the stent landing
zones were obtained. All measurements
were evaluated in respect to immediate
and long-term flow modifications and
size regressions (Fig 2) of the ipsilateral
A1 segment documented by MRA (with-
out and with contrast) at 3 months post-
embolization, and by formal angiography
at 6-month follow-up. We describe the
flow modification in the ipsilateral A1
segment as follows: 1) no change of flow,
2) antegrade flow retardation, and 3)
complete reversal of flow (Fig 3).
Immediate andmidterm clinical assess-
ments were also obtained and reviewed.
Preoperative Preparation and
Procedure
All patients were started on dual anti-
platelet therapy before procedures. A
P2Y12 assay (VerifyNow; Accumetrics,
San Diego, California) was obtained in all
patients to evaluate and confirm the level
of platelet inhibition obtained by the dual
antiplatelet regimen.
A 4-vessel diagnostic angiogram was
performed, inclusive of 3D reconstructed images. A thorough an-
giographic assessment of flow dynamics in the anterior circle of
Willis, with emphasis on the bilateral ACAs and the AcomA com-
plex was performed. We evaluated the collateral flow from the
contralateral A1 segment through the AcomA into both proximal
A2 segments, and the retrograde flow, across the midline, into the
ipsilateral A1 segment. In cases where the standard angiographic as-
sessment was not conclusive, we used cross-compression of the ipsi-
lateral common carotid artery with concomitant contralateral ICA
injection. This allowed preliminary assessment of reversal of flow in
the A1 segment/AcomA complex.
FIG 1. A, A DSA 3D reconstruction of a superior hypophyseal wide-neck aneurysm (1 small
additional aneurysm is seen at the AchoA level). B, The aneurysm was treated with coil embo-
lization and 1 PED, covering the right A1 segment. Postembolization injection demonstrates
ﬁlling of a large A1 segment through the PED.
FIG 2. Follow-up TOF MRA at 3 months postprocedure demonstrates regression of the ipsilat-
eral A1 segment and complete occlusion of the aneurysms.
FIG 3. A, Seven-month follow-up angiography demonstrates complete aneurysmal occlusion with
no antegrade ﬁlling of the ipsilateral A1 segment through the ﬂow diverter. B, Contralateral ICA
injectiondemonstratescomplete reversalofﬂowandﬁllingof the ipsilateralA1 segmentperforators.
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All embolization procedures were performed via standard
transfemoral approach under full heparinization using the com-
bination of platinum and hydrogel coils. The dimensions of the
Pipeline Embolization Device were chosen for each case after
quantitation of the size of the aneurysmal neck, the landing zones
length, and both the M1 segment and the ICA diameters. We
attempted tomatch the size of the nominal PED diameter relative
to the proximal landing zone in the ICA. Accordingly, the PED
was oversized inmost cases in respect to the distal landing zone in
the M1 segment.
Measurements of the Vessel Diameters
All vessel measurements were obtained on the original calibrated
DSA images. Vessel diameters of the ipsilateral M1 segment and
the ICAwere obtained from injections before PED deployment at
the region of the expected landing sites of the proximal and distal
ends of the PED. Measurements of the PED landing length in the
M1 segment were defined as the distance from the orifice of the
M1 segment at the ICAb to the distal end of the PED. Measure-
ments of the ipsilateral A1 segment and the contralateral A1 seg-
ment, the M1 segment, and the supraclinoid ICA were evaluated
at a distance of 5 mm from the ICAb.
RESULTS
Clinical Results
We treated 7 patients where a single PED was deployed from the
mid- and proximal M1 segment into the supraclinoid ICA (On-
line Table). In the cohort, 5 patients werewomen.Median agewas
62 years (range 35–72). Four patients were treated for multiple
aneurysms. The following aneurysms were treated: 3 posterior
communicating artery aneurysms, 3 AchoA artery aneurysms, 4
ICAb aneurysms, and 1 A1 segment aneurysm. Clinically, all pa-
tients were stable in the immediate postprocedural period and all
had no new neurologic deficits. All patients maintained their
baseline clinical status. There were no radiographic signs of isch-
emia. One patient demonstrated asymptomatic angiographic in-
stent stenosis at the M1 segment at 6-month follow-up angiogra-
phy without neurologic sequelae. All aneurysms, with the
exception of 1 fusiform ICAb aneurysm, were completely oc-
cluded on follow-up imaging.
The ICAb aneurysm that was not completely occluded on
3-month postprocedure MRA follow-up was a fusiform aneu-
rysm. This patient also had a posterior communicating artery an-
eurysm that had recanalized after coiling in the acute hemorrhage.
The PEDwas deployed from theM1 segment to the ICA to simul-
taneously cover and treat both aneurysms. The posterior commu-
nicating artery aneurysm, which was re-
coiled during the current procedure,
demonstrated complete occlusion on
3-month follow-up MRA. The ICAb an-
eurysm demonstrated marked size reduc-
tion, but did not demonstrate complete
occlusion. This patient is pending mid-
term formal angiographic follow-up.
Flow Modiﬁcation Results
Immediate antegrade flow retardation in
the ipsilateral A1 segment, post-PED de-
ployment, was noticed in 1 patient. All other patients did not
demonstrate any change of flow in ACA/AcomA complex during
immediate postembolization angiography. Six of the 7 patients
subsequently demonstrated significant delayed flow modifica-
tion. All 5 patients who underwent short term (3–4month)MRA
follow-up demonstrated size regression of the ipsilateral A1 seg-
ment. Five patients underwent midterm follow-up angiography
(5.5–12 months). Complete reversal of flow in the ipsilateral A1
segment was noted in 4 of 5 patients. One patient did not demon-
strate any flow modification. Two patients are awaiting angio-
graphic follow-up.
Baseline Anatomic Conﬁguration and Flow Modiﬁcation
All patients who demonstrated regression of the A1 segment or
reversal of flow in the AcomA complex manifested an A1 seg-
ment/M1 segment average ratio of 0.58 (range 0.29–0.76) and an
A1 segment/ICA average ratio of 0.44 (range 0.28–0.55) (Table).
The M1 segment/ICA average ratio in this group was 0.77 (range
0.64–0.93). The entirety of the group, except for 2 patients, dem-
onstrated either equal A1 segments or a dominant contralateral
A1 segment (ipsilateral A1 segment/contralateral A1 segment, av-
erage ratio 0.74 [range 0.38–0.98]).
The only patient who did not demonstrate flow modification,
immediately or in follow-up MRA imaging and formal angiogra-
phy, had a dominant ipsilateral A1 segment (ipsilateral A1 seg-
ment/contralateral A1 segment ratio of 1.42). The ratios of the A1
segment/M1 segment (1.12) and the A1 segment/ICA (0.66) were
higher in this patient relative to the rest of the patients. Interest-
ingly, the ratio between M1 segment/ICA (0.59) in this patient
was the lowest among this group.
Anatomic Conﬁguration in Respect to PED Deployed
Among the 6 patients who demonstrated flow modification, the
partial PED distance extending into the M1 segment from the
ICAb measured an average of 7.63 mm (range 4.95–16.3 mm)
(Table). The mean nominal PED/M1 segment ratio was found to
be oversized at 1.36 (range 1.3–1.59). The patient who did not
demonstrate any flowmodification had a short length (0.97 mm)
of PED in the M1 segment. In addition, in this case we had the
highest oversized PED in respect to the M1 segment diameter at
the landing zone (ratio 1.72).
DISCUSSION
Modification of flow in the ACA-AcomA complex by the tech-
nique we propose highlights an important hemodynamic concept
that has been previously described in other territories—branch













1 0.29 0.28 0.88 1.34 0.38
2 1.12 0.66 0.59 1.72 1.42
3 0.5 0.38 0.76 1.3 0.79
4 0.66 0.45 0.68 1.45 0.75
5 0.72 0.46 0.64 1.59 0.98
6 0.76 0.55 0.73 1.36 1.44
7 0.57 0.53 0.93 1.09 0.79
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vessel and perforator patency is intimately related to flow demand
and potential collateralization.3,6-8
Flow modification and persistence of flow in adjacent branch
vessels using a FD, distinct from the parent vessel itself, have been
previously described both in animal model laboratory studies, as
well as in clinical case series studies.6,8-11 The patency of the oph-
thalmic artery (OphA) covered by FDs was examined.8 In this
study, 21% of the OphAs were occluded, all without visual
changes or clinical symptoms. Only 2 patients who demonstrated
OphA occlusion demonstrated collateral retrograde flow into the
OphA. The flow and vascular contribution of these more distal
collateral vessels might be the reason for proximal occlusion of
branch vessels such as the OphA when using FDs. Importantly,
when there is a positive flow/pressure gradient (or persistent “de-
mand”), critical perforators and end-arteries will remain patent,
even if covered by a FD. Conversely, when the demand is not
present, flow regression and/or vessel occlusion is predicted.3,8
Based on these concepts, the placement of a PED was de-
scribed recently for the treatment of distal MCA aneurysms.4,6,7
Among a series of 26 patients, there were 12 patients who all
remained asymptomatic, with reduced flow or occlusion of an
MCA branch vessel. Similar to flow modification seen at the
OphA region, this phenomenon is most likely dependent on the
effectiveness and competency of the regional pial collaterals.6 An
additional report describes the deployment of a PED in an MCA
trunk that did not harbor the aneurysm (“competitive” vessel),
thus covering the vessel harboring the aneurysm. In long-term
follow-up studies, the parent vessel and aneurysm were occluded
with reconstitution of the distal territory by pial leptomeningeal
collaterals.7 Again, adequate collateralization was noted in tan-
dem with flow reduction or vessel occlusion related to PED
placement.
In our study, we observed size regression of the ipsilateral A1
segment compared with the immediate postprocedure angio-
graphic studies, and significant flow modification at the level of
the ICAb. A reversal of flow was documented, characterized by
retrograde filling of the ipsilateral A1 segment from the contralat-
eral A1 segment through the AcomA, which was consistent with
quantitated anatomic configurations (A1 segment/M1 segment
average ratio of 0.58, an A1 segment/ICA average ratio of 0.44,
and ipsilateral A1 segment/contralateral A1 segment average ratio
0.74). Medial lenticulostriate arteries on the ipsilateral A1 seg-
ment maintained persistent patent flow dependent on the con-
tralateral A1 segment flow through the AcomA. We noted that in
cases where there was reduced demand on the ipsilateral A1 seg-
ment with concurrent robust collateral flow from the contralat-
eral A1 segment, the ipsilateral vessel demonstrated early regres-
sion. This parallels the observations seenwith theOphAandMCA
aneurysms and further supports the relationship of vascular “de-
mand” and potential flow regression.3,6-8 Our experience with 7
patients demonstrated that ipsilateral A1 regression was not asso-
ciatedwith any clinical symptomatology or ischemic lesionsman-
ifest on imaging, as the A1 segment perforators will “demand” the
flow from the adequate collateralization from the contralateral A1
segment.
We believe that in cases where the contralateral A1 segment or
the AcomA are hypoplastic, there is a high demand on the ipsilat-
eral A1. Thus, this ipsilateral A1 segment will not regress and will
maintain antegrade filling, resembling a perforator with no col-
lateralization covered by a PED. Accordingly, in our cohort, the 1
case that maintained antegrade filling without size regression had
an anatomic configuration suggestive of high demand on the ip-
silateral A1 segment. Here we noted a dominant ipsilateral A1
segment (ipsilateral A1 segment/contralateral A1 segment ratio of
1.42), and high ratios of the A1 segment/M1 segment and the A1
segment/ICA (1.12 and 0.66, respectively). Several other factors,
however, may have played a role in the persistent flow in this
scenario. Only a minimal length of PED was deployed in the M1
segment, and therefore the PED might have provided only a lim-
ited flow diversion at the level of the ICAb. A second factor that
might have impacted on flow diversion at the ICAb is the sizing of
the PED in respect to the vessel diameter at the M1 segment’s
landing zone. In the same patient, we had markedly oversized the
PED in respect to the M1 segment diameter, to match the supra-
clinoid ICA diameter. This differential might have created a
higher PED porosity that impacted the flow diversion effect.12
In a series recently published of MCA aneurysms treated by
FDs, 1 patient had a PED deployment that covered the A1 seg-
ment. This patient’s course was complicated by a TIA with dem-
onstration of flow attenuation in the A1 segment. Of note, this
patient was treatedwith 2 PEDs and had discontinued antiplatelet
therapy. Questionable patency of the ipsilateral A1 segment or
impingement on the patency of M1 perforators may have been
associated with the clinical course in this setting. Thus, we do not
cover the A1 segment origin with more than 1 PED to allow for
potential adequate flow as per its demand.
Study Limitations
Our series is limited in size, composed of 7 cases that were treated
by the same technique.We presentedmidterm clinical and angio-
graphic follow-up of the flow modification observed in the ACA-
AcomA complex.We have attempted to correlate the vessel diam-
eter ratios with the prediction of future modification of flow; this
quantitation, however, is a preliminary assessment that will need
to be verified by a larger series of patients and longer periods of
clinical and imaging follow-up.
CONCLUSIONS
We found that the deployment of a single PED extending from the
supraclinoid ICA to theM1 segment may result in flowmodifica-
tion marked by retrograde filling as well as regression of the ipsi-
lateral A1 segment. Flow modification is usually predictable ac-
cording to quantitatable anatomic configurations.Deployment of
a single PED, when deemed necessary, may be used safely in the
treatment of selected aneurysms located in the distal supraclinoid
ICA, ICAb, and the A1 and M1 segments.
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